An Efficacy and Safety Study of Subcutaneous Tocilizumab in Combination With Methotrexate (MTX) and as Monotherapy Versus MTX in Participants With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Current Disease-Modifying Antirheumatic Drug (DMARD) Therapy
Clinical trial NCT03155347 · COMPLETED
Trial details
- NCT number
- NCT03155347
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-02
- Primary completion
- 2022-08-08
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.